Optimal antimicrobial therapy and antimicrobial stewardship in sepsis and septic shock

被引:1
|
作者
Seok, Hyeri [1 ]
Park, Dae Won [1 ]
机构
[1] Korea Univ, Ansan Hosp, Coll Med, Div Infect Dis,Dept Med, Ansan, South Korea
来源
关键词
Sepsis; Septic shock; Anti-infective agents; Anti-bacterial agents; Antibiotic stewardship; ANTIBIOTIC-THERAPY; INTENSIVE-CARE; DE-ESCALATION; CLINICAL-OUTCOMES; BLOOD CULTURE; ORGAN FAILURE; PROCALCITONIN; MORTALITY; IMPACT; RESISTANCE;
D O I
10.5124/jkma.2019.62.12.638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The management of sepsis and septic shock remains challenging. The aim is to apply the optimal antimicrobial therapy and antimicrobial stewardship to patients in state of sepsis or septic shock. To reduce the mortality of sepsis and septic shock, it is critical to promptly administer the appropriate antibiotics with an accurate diagnosis. De-escalation is needed 48 to 72 hours after the first administration of antibiotics depending on the findings of causative pathogens. In the case of antibiotic resistance, the importance of an antibiotic stewardship program is increasingly being emphasized. Antimicrobial stewardship implies coordinated interventions designed to improve the appropriate use of antibiotics by promoting the selection of an optimal drug regimen such as dosing, duration of therapy, and route of administration. An antibiotic stewardship program may also be applied to patients of both sepsis and septic shock. Efforts such as the selection of appropriate empirical antibiotics, de-escalation, and determination of whether to stop antibiotics with procalcitonin may improve the clinical prognosis of patients with sepsis as well as the successful implementation of an antibiotic stewardship program.
引用
收藏
页码:638 / 644
页数:7
相关论文
共 50 条
  • [1] Antimicrobial Therapy and Antimicrobial Stewardship in Sepsis
    Seok, Hyeri
    Jeon, Ji Hoon
    Park, Dae Won
    [J]. INFECTION AND CHEMOTHERAPY, 2020, 52 (01): : 19 - 30
  • [2] Optimizing Antimicrobial Therapy in Sepsis and Septic Shock
    Kumar, Anand
    [J]. CRITICAL CARE CLINICS, 2009, 25 (04) : 733 - +
  • [3] Optimizing Antimicrobial Therapy in Sepsis and Septic Shock
    Kumar, Anand
    [J]. CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2011, 23 (01) : 79 - +
  • [4] Optimizing Antimicrobial Therapy of Sepsis and Septic Shock Preface
    Kumar, Anand
    [J]. CRITICAL CARE CLINICS, 2011, 27 (01) : XI - XII
  • [5] Early antimicrobial therapy in severe sepsis and septic shock
    Kumar A.
    [J]. Current Infectious Disease Reports, 2010, 12 (5) : 336 - 344
  • [6] Sepsis and septic shock: Selection of empiric antimicrobial therapy
    Cunha, Burke A.
    [J]. CRITICAL CARE CLINICS, 2008, 24 (02) : 313 - +
  • [7] Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance
    Strich, Jeffrey R.
    Heil, Emily L.
    Masur, Henry
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 222 : S119 - S131
  • [8] Antimicrobial Management of Sepsis and Septic Shock
    Sharma, Sat
    Kumar, Anand
    [J]. CLINICS IN CHEST MEDICINE, 2008, 29 (04) : 677 - +
  • [9] Optimizing Antimicrobial Therapy of Sepsis and Septic Shock: Focus on Antibiotic Combination Therapy
    Vazquez-Grande, Gloria
    Kumar, Anand
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) : 154 - 166
  • [10] Optimal antimicrobial therapy for sepsis
    Fish, DN
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 : S13 - S19